For example, CD19, a common marker of B cells, is present among 95% of acute lymphoblastic leukemia cells, but its abundance among myeloma cells varies between 10 and 80% depending on the patient (Nerreter et al. 2019). Here, CD19 is linked to plasma cell myeloma.